| abstract |
The present invention provides an immunoconjugate comprising (a) one or more antigen-binding moieties and effector moieties, and (b) increased effector function for use in treating a disease in a subject in need thereof. Combinations of antibodies engineered to have are provided. In addition, pharmaceutical compositions comprising the combinations and methods of using the same are provided. |